DREAMM-9: Phase I Study of Belantamab Mafodotin with Standard of Care in non-transplant-eligible Patients with newly diagnosed multiple Myeloma
ONCOLOGY RESEARCH AND TREATMENT(2022)
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined